Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Alkermes Begins Phase 2 Study To Evaluate Clinical And Immunologic Activity Of ALKS 4230 In Advanced Solid Tumors


RTTNews | Aug 19, 2020 07:01AM EDT

07:01 Wednesday, August 19, 2020 (RTTNews) - Alkermes Begins Phase 2 Study To Evaluate Clinical And Immunologic Activity Of ALKS 4230 In Advanced Solid Tumors

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC